Journal: Aging Cell
Article Title: Tgm2‐Catalyzed Covalent Cross‐Linking of IκBα Drives NF ‐ κB Nuclear Translocation to Promote SASP in Senescent Microglia
doi: 10.1111/acel.14463
Figure Lengend Snippet: CD treatment reduces SASP factors in senescent BV2 cells. (A) SA‐β‐Gal staining results of BV2 cells. Ctrl, control cells; Sene, Senescent cells. Sene+CD: BV2 cells were treated with 10 μM etoposide and 500 μM CD together. Scale bar: 50 μm. (B, C) RT‐qPCR was used to measure mRNA levels of IL6 , MMP3 , MMP12 , CXCL1 , CXCL2 , CXCL10 , P21 , and P53 ( n = 3). Ctrl, control cells. CD: BV2 cells were treated with 500 μM CD. ETOP: BV2 cells were treated with 10 μM etoposide to induce DNA damage‐induced senescence. ETOP+CD: BV2 cells were treated with 10 μM etoposide and 500 μM CD together. (D) RT‐qPCR was used to measure mRNA levels of IL6 , MMP3 , and CXCL1 ( n = 4). NC, negative control BV2 cells. NC + ETOP: Negative control BV2 cells were treated with 10 μM etoposide. TKD + ETOP: BV2 cells with Tgm2 knockdown were treated with 10 μM etoposide. Data were analyzed by one‐way ANOVA or Student's t ‐test. p > 0.05 is indicated by ns; p < 0.05 is indicated by ⁎; p < 0.01 is indicated by ⁎⁎; p < 0.001 is indicated by ⁎⁎⁎; p < 0.0001 is indicated by ⁎⁎⁎⁎.
Article Snippet: Cys‐D (Cat# A53299, China) was purchased from OKA, Tg2‐IN1 (Cat# HY117678 , USA) was purchased from MCE, and etoposide (Cat# SC0173, China) was purchased from Beyotime.
Techniques: Staining, Control, Quantitative RT-PCR, Negative Control, Knockdown